Shire Pharmaceuticals LLC Formerly Known as Shire Regenerative Medicine

regenerative medicine company; develops and commercializes bioengineered tissue products

Based in CT

🤖

AI Overview

With $220K in lobbying spend across 6 quarterly filings, Shire Pharmaceuticals LLC Formerly Known as Shire Regenerative Medicine is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2018 to 2019.

$220K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$180K
2019	$40K

Issues Lobbied

Medicare/Medicaid Taxation Health Issues Budget/Appropriations

Lobbying Firms

Williams and Jensen, PLLC

Lobbyists

Karina Lynch George Olsen Cheryl Jaeger Christopher Hatcher Matthew Hoekstra Susan Hirschmann Melinda Maxfield

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Taxation, Health Issues, Budget/Appropriations

•Medicare and Medicaid reimbursement policies and Part B payment reform.

•Tax issues affecting the pharmaceutical industry; Foreign direct investment, orphan drug tax credit, tax issues; Implementation of H.R. 1, Tax Cuts and Jobs Act.

•H.R. 1628, American Healthcare Act of 2017; General education about policies that impact pharmaceutical development approval and reimbursement; FDA Reauthorization Act of 2017; general education about